E‑News Updates
-
May 16, 2022Tags: ACA, ACA tax credits, biden administration, cancer, CMS, drug prices, HHS, insulin, legislation, mental health, private healthcare
-
May 9, 2022Tags: ACA, ACA tax credits, biden administration, CHIP, CMS, COVID-19, GAO, HHS, insulin, legislation, private healthcare
-
May 2, 2022Tags: biden administration, budget, CHIP, CMS, cost-sharing, COVID-19, health equity, HHS, insulin, legislation, MedPAC, No Surprise Act, private healthcare
-
April 25, 2022Tags: biden administration, budget, CHIP, CMS, COVID-19, health equity, HHS, insulin, legislation, MedPAC, No Surprise Act, private healthcare
-
April 18, 2022Tags: ACA, biden administration, bipartisan, budget, CHIP, CMS, COVID-19, drug pricing, drug rebates, fda, FTC, HHS, insulin, legislation, Medicaid, MedPAC, mental health, omnicron, reconciliation, senate finance committee
Roundtable Activity
-
April 4, 2022Tags: ACA, biden administration, bipartisan, budget, CHIP, CMS, COVID-19, drug pricing, drug rebates, fda, FTC, hcbs, HHS, insulin, legislation, Medicaid, mental health, reconciliation, senate finance committee, title xRoundtable News Top News Administrative Action Regulatory Action Congressional Action Marketplace Medicaid Roundtable News Save-the-Date – Wednesday, April 13th at 3:00 PM (EDT) “Biosimilars in the U.S.: Benefits, Public Policies and Opportunities – A Roundtable Webinar” Please plan to join us on April 13th for a webinar: “Biosimilars in the U.S.: Benefits, Public Policies and […]
-
March 28, 2022Tags: ACA, ACO Reach, ahip, bipartisan, CHIP, CMS, COVID-19, drug pricing, drug rebates, fda, hcbs, HHS, insulin, Joe Biden, legislation, Medicaid, medicare, Medicare Part B, osha, reconciliation, senate finance committeeRoundtable News Top News Administrative Action Congressional Action Marketplace Medicare Medicaid Research Roundtable News Save-the-Date – Wednesday, April 13th at 3:00 PM (EDT) “Biosimilars in the U.S.: Benefits, Public Policies and Opportunities – A Roundtable Webinar” Please plan to join us on April 13th for a webinar: “Biosimilars in the U.S.: Benefits, Public Policies and […]
Activity Archive